These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 9215027
1. Heterogeneous effects of protamine on human mast cells and basophils. Patella V, Ciccarelli A, Lamparter-Schummert B, de Paulis A, Adt M, Marone G. Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027 [Abstract] [Full Text] [Related]
2. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Marone G, Stellato C, Mastronardi P, Mazzarella B. Ann Fr Anesth Reanim; 1993 Jun; 12(2):116-25. PubMed ID: 7690200 [Abstract] [Full Text] [Related]
3. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. Patella V, de Crescenzo G, Marino O, Spadaro G, Genovese A, Marone G. Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840 [Abstract] [Full Text] [Related]
4. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G. Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014 [Abstract] [Full Text] [Related]
5. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. Genovese A, Stellato C, Patella V, Lamparter-Schummert B, de Crescenzo G, Adt M, Marone G. Int J Clin Lab Res; 1996 Nov; 26(3):192-8. PubMed ID: 8905451 [Abstract] [Full Text] [Related]
7. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells. Patella V, Bouvet JP, Marone G. J Immunol; 1993 Nov 15; 151(10):5685-98. PubMed ID: 7693815 [Abstract] [Full Text] [Related]
10. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. de Paulis A, Ciccarelli A, Marinò I, de Crescenzo G, Marinò D, Marone G. Arthritis Rheum; 1997 Mar 15; 40(3):469-78. PubMed ID: 9082935 [Abstract] [Full Text] [Related]
11. Human heart mast cells: a definitive case of mast cell heterogeneity. Patella V, de Crescenzo G, Ciccarelli A, Marinò I, Adt M, Marone G. Int Arch Allergy Immunol; 1995 Apr 15; 106(4):386-93. PubMed ID: 7536502 [Abstract] [Full Text] [Related]
12. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G. J Pharmacol Exp Ther; 1993 Dec 15; 267(3):1375-85. PubMed ID: 7505332 [Abstract] [Full Text] [Related]
13. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin. Marone G, Columbo M, Galeone D, Guidi G, Kagey-Sobotka A, Lichtenstein LM. Agents Actions; 1986 Apr 15; 18(1-2):100-2. PubMed ID: 2425566 [Abstract] [Full Text] [Related]
14. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. Columbo M, Horowitz EM, Botana LM, MacGlashan DW, Bochner BS, Gillis S, Zsebo KM, Galli SJ, Lichtenstein LM. J Immunol; 1992 Jul 15; 149(2):599-608. PubMed ID: 1378071 [Abstract] [Full Text] [Related]
20. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A, Formisano S. Biochem Pharmacol; 1987 Jan 01; 36(1):13-20. PubMed ID: 2432900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]